MgrB Alterations Mediate Colistin Resistance in Klebsiella pneumoniae Isolates from Iran

Colistin is one of the last-resort therapeutic agents to combat multidrug-resistant Gram-negative bacteria (GNB) including . Although it happens rarely, resistance to colistin has been reported for several GNB. A total of 20 colistin resistant (col-R) and three colistin susceptible (col-S) clinical...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 8; p. 2470
Main Authors Haeili, Mehri, Javani, Afsaneh, Moradi, Jale, Jafari, Zeinab, Feizabadi, Mohammad M, Babaei, Esmaeil
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 18.12.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Colistin is one of the last-resort therapeutic agents to combat multidrug-resistant Gram-negative bacteria (GNB) including . Although it happens rarely, resistance to colistin has been reported for several GNB. A total of 20 colistin resistant (col-R) and three colistin susceptible (col-S) clinical isolates of were studied to explore the underlying mechanisms of colistin resistance. The presence of plasmid encoded resistance genes, genes were examined by PCR. The nucleotide sequences of , and genes were determined. To evaluate the association between colistin resistance and upregulation of and operons, transcriptional level of the and genes encoding for lipopolysaccharide target modifying enzymes was quantified by RT-qPCR analysis. None of the plasmid encoded resistance genes were detected in the studied isolates. Inactivation of MgrB due to nonsense mutations and insertion of IS elements was observed in 15 col-R isolates (75%). IS elements (IS -like and IS -like families) most commonly targeted the coding region and in one case the promoter region of the Complementation with wild-type MgrB restored colistin susceptibility in isolates with altered . All col-R isolates lacked any genetic alterations in the , and genes and substitutions identified in the were not found to be involved in resistance conferring determined by complementation assay. Colistin resistance linked with upregulation of and operons with the and being overexpressed in 20 and 11 col-R isolates, respectively. Our results demonstrated that MgrB alterations are the major mechanisms contributing to colistin resistance in the tested isolates from Iran.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Grégory Resch, University of Lausanne, Switzerland
Reviewed by: Laurent Poirel, University of Fribourg, Switzerland; Jian-Hua Liu, South China Agricultural University, China
This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2017.02470